• 1. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 2. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 3. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 4. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

L-2-Amino-4-methoxy-trans-but-3-enoic Acid (CAS No. 35891-72-6): A Comprehensive Overview

L-2-Amino-4-methoxy-trans-but-3-enoic Acid (CAS No. 35891-72-6) is a unique and versatile compound that has garnered significant attention in the fields of chemistry, biology, and pharmaceutical research. This compound, also known as L-AMTB, is a chiral amino acid derivative with a distinct structural feature: a methoxy group attached to the butenoic acid moiety. The presence of this methoxy group imparts unique chemical and biological properties, making it a valuable candidate for various applications.

The chemical structure of L-2-Amino-4-methoxy-trans-but-3-enoic Acid consists of a four-carbon chain with a double bond in the trans configuration, an amino group, and a methoxy group. This combination of functional groups provides a rich platform for exploring its reactivity and biological activity. Recent studies have highlighted its potential in areas such as enzyme inhibition, drug delivery systems, and as a building block for more complex molecules.

In the realm of pharmaceutical research, L-2-Amino-4-methoxy-trans-but-3-enoic Acid has shown promise as a lead compound for the development of novel therapeutics. One notable area of interest is its role in modulating enzyme activity. Enzymes are crucial catalysts in biological systems, and their inhibition can have significant therapeutic effects. Research has demonstrated that L-AMTB can selectively inhibit certain enzymes, making it a potential candidate for treating diseases characterized by enzyme dysregulation.

Moreover, the chiral nature of L-2-Amino-4-methoxy-trans-but-3-enoic Acid adds another layer of complexity to its potential applications. Chirality is a fundamental concept in organic chemistry and plays a critical role in drug design and development. The enantiomeric purity of compounds can significantly affect their biological activity and pharmacokinetic properties. Studies have shown that the L-enantiomer of L-AMTB exhibits superior biological activity compared to its D-enantiomer, further underscoring its importance in pharmaceutical research.

Beyond its direct therapeutic applications, L-2-Amino-4-methoxy-trans-but-3-enoic Acid has also been explored as a building block for more complex molecules. Its unique structure makes it an ideal starting material for synthetic routes leading to compounds with diverse functionalities. For instance, it can be used as an intermediate in the synthesis of peptidomimetics, which are molecules designed to mimic the structure and function of peptides but with improved stability and bioavailability.

In addition to its chemical properties, the biological activity of L-2-Amino-4-methoxy-trans-but-3-enoic Acid has been extensively studied. One area of focus is its potential as an antioxidant. Oxidative stress is implicated in various diseases, including neurodegenerative disorders and cardiovascular diseases. Research has shown that L-AMTB possesses antioxidant properties, which could make it useful in developing treatments for these conditions.

The pharmacological profile of L-2-Amino-4-methoxy-trans-but-3-enoic Acid has also been investigated. Preclinical studies have demonstrated its ability to cross the blood-brain barrier (BBB), which is a significant advantage for compounds targeting central nervous system (CNS) disorders. This property makes it an attractive candidate for developing drugs that can effectively reach and act on brain tissues.

Clinical trials are currently underway to evaluate the safety and efficacy of L-2-Amino-4-methoxy-trans-but-3-enoic Acid in various therapeutic contexts. Early results have been promising, with the compound showing good tolerability and pharmacokinetic profiles. However, further research is needed to fully understand its potential benefits and any potential side effects.

In conclusion, L-2-Amino-4-methoxy-trans-but-3-enoic Acid (CAS No. 35891-72-6) is a multifaceted compound with significant potential in both fundamental research and applied pharmaceutical development. Its unique chemical structure and biological properties make it an exciting candidate for further exploration and application in various fields. As research continues to advance, it is likely that new applications and insights will emerge, further solidifying the importance of this compound in the scientific community.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)